General
Preferred name
PELUBIPROFEN
Synonyms
Pelubiprofene ()
Pelubiprofeno ()
RS-2131 ()
CS-670 ()
P&D ID
PD058650
CAS
69956-77-0
Tags
drug
available
Drug indication
Back pain
Rheumatoid arthritis
Drug Status
investigational
approved
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Pelubiprofen is an orally active anti-inflammatory agent that inhibits COX enzyme activity (with IC50 values of 10.66 and 2.88 ¦ÌM for COX-1 and COX-2, respectively). Pelubiprofen has significant anti-inflammatory and analgesic effects[1][2].
PRICE 48
DESCRIPTION Pelubiprofen is an orally active, non-steroidal anti-inflammatory agent, a selective cyclooxygenase-2 (COX-2) inhibitor, which effectively reduces PGE(2) production by inhibiting COX activity. Pelubiprofen inhibits LPS-induced phosphorylation of IKK-?? and transforming growth factor-?? activated kinase-1 (TAK1).
DESCRIPTION Pelubiprofen is a nonsteroidal anti-inflammatory type compound . Structurally it is an aryl propionic acid derivative, like . The INN-defined agent is a racemic mixture of enantiomers. We show the structure without specified stereochemistry to represent the mixture. Pelubiprofen is described as a prodrug of 2-arylpropionic acid with modest selectivity for COX2 . (GtoPdb)
DESCRIPTION Pelubiprofen is an orally active, non-steroidal anti-inflammatory agent, a selective cyclooxygenase-2 (COX-2) inhibitor, which effectively reduces PGE(2) production by inhibiting COX activity. Pelubiprofen inhibits LPS-induced phosphorylation of IKK-β and transforming growth factor-β activated kinase-1 (TAK1). (TargetMol Bioactive Compound Library)
Compound Sets
7
ChEMBL Drugs
CHEMBL69308
DrugBank
DB12150
DrugMAP
DM8DQV9
DrugMAP Approved Drugs
DM8DQV9
Guide to Pharmacology
9876
MedChem Express Bioactive Compound Library
HY-12383
TargetMol Bioactive Compound Library
T16464
External IDs
22
Properties
(calculated by RDKit )
Molecular Weight
258.13
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
1
cLogP
3.4
TPSA
54.37
Fraction CSP3
0.38
Chiral centers
1.0
Largest ring
6.0
QED
0.85
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
COX-2
COX
IKK
MAP3K
NF-κB
NO Synthase
Pathway
Immunology/Inflammation
MAPK/ERK Pathway
Neuroscience
NF-¦ÊB
Source data